China Biotech In Review: SciClone Pharma In-Licenses China Rights To Heart ... Seeking Alpha SciClone Pharma (NSDQ: SCLN) in-licensed China rights to a heart failure drug from Zensun (Shanghai) Science & Technology Co. (see story). SciClone, which is headquartered in the US, usually markets western drugs in China. This time, the company has ... |
